Plain-English translation of NCT05260125 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After a stroke, many people experience severe shoulder pain on the paralyzed side of their body, which can slow recovery. This trial is testing a treatment called a suprascapular nerve block—an injection that numbs the nerve responsible for most shoulder sensation. The study compares two ways of delivering this injection: one using ultrasound imaging to guide the needle precisely, and another using anatomical landmarks on the body to guide placement.
Shoulder pain after stroke is common and makes rehabilitation harder, but doctors aren't sure whether using ultrasound to guide the nerve block injection works better than the traditional method. This study will help determine which approach provides better pain relief.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive the nerve block injection using either ultrasound guidance or traditional landmark-based guidance. The researchers will collect information about your medical history, stroke details, and baseline pain levels. You will then receive the single injection procedure and be monitored to see how well it reduces your shoulder pain over time as you continue your regular rehabilitation.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
Turkey (Türkiye)
Phase
Post-approval monitoring
Sponsor
Abant Izzet Baysal University
Enrollment target
~50 participants
Started
March 2022
Primary completion
March 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
25 Years – 75 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Serdar Kılınç
Abant Izzet Baysal University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.